- Clinical Trials
William Gannon, MD, MBA joins Genprex as the Company’s Vice President of Regulatory Affairs. Dr. Gannon brings more than 30 years of experience in the biotech and pharmaceutical industries to the Company, with expertise in clinical development, regulatory affairs and commercialization of products, and a strong background in oncology and gene therapy.
Dr. Gannon is responsible for managing the Company’s regulatory affairs for its upcoming clinical trials, and he also serves as the Medical Monitor, interfacing with medical personnel at trial sites and assisting with FDA communication throughout the clinical trials.
He has held several executive roles at various biotech, pharmaceutical and medical device companies, overseeing regulatory affairs, both U.S. and international, for filings, meetings, submissions and approvals.
He has served on the Institutional Review Board (IRB), Board of Directors and Clinical Advisory Board of several organizations and is an active member of research and professional affiliations, including the AdvaMed (Advance Medical Technology Association), the Drug Information Association, the Regulatory Affairs Professioonal Society and the American Academy of Pharmaceutical Physicians and Investigators.